300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Cannabis
Infrastructure
Mobile Apps
LGBT
Life Science
Wine and Spirits
Celebrity
Food and Beverage
Publishing
Climate
Music
Art
Real Estate
Manufacturing
Sporting Goods
Financial Services
Social Media
Digital Media
Franchise
Mobile Advertising
FinTech
Finance
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Katerina Stroponiati, Founding Partner at Monday Capital

Katerina Stroponiati

Founding Partner @ Monday Capital

San Francisco, United States

Katerina Stroponiati is a pre-seed investor at Monday Capital in San Francisco focused on Medical and Life Science. Katerina Stroponiati is the founder of Brilliant Minds, pioneering a visionary approach in venture capital by focusing on founders over 50, challenging age-related stigmas in entrepreneurship. Brilliant Minds is a longevity intervention with a twist, demonstrating that older individuals can be innovative and forward-thinking. Previously,Katerina's two tech startups had successful exits. With an engineering background and experience as an ex-startup founder and founding partner of Monday Capital, Katerina brings a unique perspective to the field of entrepreneurship.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries Katerina Stroponiati invests in

MedicalLife ScienceTherapeuticsBiotechnology

Stages Katerina Stroponiati invests in

Pre-Seed

Investment Focus

Industry

  • Medical 1 (100%)
  • Life Science 1 (100%)
  • Therapeutics 1 (100%)
  • Biotechnology 1 (100%)

Investments

CompanyDescriptionRoundLinks
Biophysical Therapeutics Biophysical Therapeutics
Biophysical Therapeutics uses computational biology to design new drugs. It has a pipeline of experimentally-validated new drugs. Its primary targets are cancer, diseases of aging (e.g., Alzheimer's disease), and aging itself. Also pursuing cosmetics. Has a record of discovering new fundamental biology. Owns [by granted patents] inventedpreclinical, and repurposed clinical, stage drugs. Company has and is prosecuting longevity drug candidates (drugs to slow, halt or reverse aging). A longevity company. Professor George Church (of Harvard Medical School) is an Advisor. Scientist founder, Dr. Michael Forrest, is a Cambridge University biochemistry graduate with a Ph.D. in computer science. $190K / Pre-Seed / Jun 05, 2023

Co-Investors

Monday Capital

About Monday Capital

VC Fund · San Francisco, United States

Venture Capital with a focus on Blockchain, AI and VR

Monday Capital Contacts

NameEmailPhoneSocials
Katerina Stroponiati
Katerina Stroponiati Founding Partner

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open Monday Capital full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Cannabis
Infrastructure
Mobile Apps
LGBT
Life Science
Wine and Spirits
Celebrity
Food and Beverage
Publishing
Climate
Music
Art
Real Estate
Manufacturing
Sporting Goods
Financial Services
Social Media
Digital Media
Franchise
Mobile Advertising
FinTech
Finance
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Katerina Stroponiati invest in?

Katerina Stroponiati invests primarily in Medical, Life Science and Therapeutics startups, most often at Pre-Seed stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Katerina Stroponiati last invest?

The most recent investment recorded for Katerina Stroponiati closed in Jun 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Katerina Stroponiati Katerina Stroponiati Find email